Alzamend Neuro (ALZN) Live Share Price, Invest From India

Alzamend Neuro Stock Performance

as on August 19, 2026 at 6:04 am IST

Day's Low
Day's High
$1.51
Day's Price Range
$1.57
$1.52
0.66%
Downside
3.29%
Upside
52 Week's Low
52 Week's High
$0.84
52-Week Price Range
$2.68
$1.52
44.74%
Downside
76.32%
Upside

Alzamend Neuro share price movements today

Previous Close: $1.58
Open: $1.52
Volume: 247.4K
Market Cap: $7.4M
Day's Low - High: $1.51 - $1.57
52 Week Low - High: $0.84 - $2.68

Alzamend Neuro Historical Returns

1 Month Return: + 28.1 %
3 Month Return: + 51.96 %
1 Year Return: -34.74 %
3 Year Return: -99.59 %
5 Year Return: -99.97 %

Alzamend Neuro Stock Fundamentals & Key Indicators

Check Alzamend Neuro market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.4M

EPS (TTM)

-2.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-8.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-373.18%

Alzamend Neuro vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alzamend Neuro with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Alzamend Neuro	BUY	$7.4M	-99.97%	NA	0.00%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for Alzamend Neuro Stock including INR - Dollar returns

The Alzamend Neuro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Alzamend Neuro investment value today

Current value as on today

₹70,127

Returns

-₹29,873

(-29.87%)

Returns from Alzamend Neuro Stock

-₹36,000 (-36%)

Dollar Impact

₹6,127 (+6.13%)

Analyst Recommendation on Alzamend Neuro Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Alzamend Neuro. Average target price of $25

Alzamend Neuro Share Price Target

Get share price movements and forecasts by analysts on Alzamend Neuro.

What analysts predicted

93.92%UPSIDE

Target Price

$25

Current Price

$1.52

Analyzed by

8 Analysts

Target

$25.00

Alzamend Neuro target price $25, a slight upside of 93.92% compared to current price of $1.52. According to 8 analysts rating.

Indian Investors' Interest in Alzamend Neuro Stock

Search interest for Alzamend Neuro Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 20, 2026 to August 19, 2026

Change:19% versus previous 30 day period

Alzamend Neuro Quarterly Profit & Loss

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Total Revenue	-	0	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-2	0	0	-1	-1	-1	-2	0	-2	-2
EBITDA	-2	0	0	-1	-1	-1	-2	0	-2	-2
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	0	0	-1	-1	-1	-2	-1	-2	-2
Income Tax Expense	0	0	-	-	-	-	-	-	-	-
Net Income	-2	0	0	-1	-1	-1	-2	-1	-2	-2
Net Profit Margin	0.00%	-1118.81%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Alzamend Neuro Annual Profit & Loss

All numbers in Millions USD

	Apr 2019	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025	Apr 2026
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	0	0	0	-
Operating Income	-5	-4	-4	-12	-14	-9	-4	-8
EBITDA	-5	-4	-4	-12	-14	-9	-4	-8
Interest Expense	-	0	0	0	0	0	0	0
Depreciation	-	-	-	0	0	0	0	0
Income Before Tax	-4	-4	-5	-12	-14	-9	-4	-8
Income Tax Expense	0	0	0	0	0	-	-	-
Net Income	-4	-4	-5	-12	-14	-9	-4	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Alzamend Neuro Quarterly Cash Flow

All numbers in Millions USD

	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Net Income	0	0	-1	0	-1	-2	-1	-2	-2
Operating Cash Flow	-1	-1	-3	-1	0	-2	-1	-1	-2
Investing Cash Flow	0	0	-	-	0	-	-	-	-
Financing Cash Flow	1	1	6	0	1	4	-	-	0
Change in Cash	0	0	2	0	0	1	-1	-1	-2

Alzamend Neuro Annual Cash Flow

All numbers in Millions USD

	Apr 2018	Apr 2019	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025	Apr 2026
Net Income	0	-4	-4	-5	-12	-14	-9	-4	-8
Operating Cash Flow	-2	-1	-2	-2	-6	-8	-8	-6	-8
Investing Cash Flow	0	0	0	0	0	-	0	0	-
Financing Cash Flow	2	0	2	4	18	0	3	10	4
Change in Cash	0	0	0	1	12	-8	-4	3	-3

Mutual Funds that own Alzamend Neuro Stock

Check out the Mutual Funds with significant holdings in Alzamend Neuro.

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	0.554374%	26563
Victory Portfolios III	0.105957%	5077
VANGUARD INDEX FUNDS	0.091828%	4400

Global Institutional Holdings in Alzamend Neuro

Funds	Holdings
Vanguard	0.16%

Insights on Alzamend Neuro

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ALZN stock has moved up by 7.5%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 515.2%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 715.3%

About Alzamend Neuro

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Organisation	Alzamend Neuro
Headquarters	3480 Peachtree Road NE, Atlanta, GA, United States, 30326
Industry	Biotechnology
CEO	Mr. Stephan Jackman
E-voting on shares	Click here to vote

Key Management of Alzamend Neuro

Name	Title
Mr. Henry C. W. Nisser Esq.	Executive VP, General Counsel & Director
Mr. Kenneth S. Cragun CPA	Senior Vice President of Finance
Mr. Stephan Jackman	CEO & Director
Mr. Milton Charles Ault III	Founder & Vice Chairman
Mr. David J. Katzoff	Chief Financial Officer

FAQs

What is Alzamend Neuro share price today?

Alzamend Neuro share price today is $1.52 as on August 19, 2026 at 12:34 am IST. Alzamend Neuro share today touched a day high of $1.57 and a low of $1.51.

What is the 52 week high and 52 week low for Alzamend Neuro share?

Alzamend Neuro share touched a 52 week high of $2.68 on October 31, 2025 and a 52 week low of $0.84 on April 13, 2026. Alzamend Neuro stock price today i.e. August 19, 2026 at 12:34 am IST is trending at $1.52,which is 43.28% down from its 52 week high and 80.95% up from its 52 week low.

What is Alzamend Neuro's market capitalisation today?

Alzamend Neuro market capitalisation is $0.00T as on August 19, 2026 at 12:34 am IST.

How to invest in Alzamend Neuro Stock (ALZN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alzamend Neuro on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alzamend Neuro Shares that will get you 0.9868 shares as per Alzamend Neuro share price of $1.52 per share as on August 19, 2026 at 12:34 am IST.

What is the minimum amount required to buy Alzamend Neuro Stock (ALZN) from India?

Indian investors can start investing in Alzamend Neuro (ALZN) shares with as little as ₹95.67 or $1 (as of August 19, 2026 at 12:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Alzamend Neuro stock (as per the Rupee-Dollar exchange rate as on August 19, 2026 at 12:44 am IST). Based on Alzamend Neuro share’s latest price of $1.52 as on August 19, 2026 at 12:34 am IST, you will get 6.5789 shares of Alzamend Neuro. Learn more about fractional shares .

What are the returns that Alzamend Neuro has given to Indian investors in the last 5 years?

Alzamend Neuro stock has given -99.97% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?